Recombinant human coagulation factor Ⅷ(Bayer HealthCare LLC Bayer HealthCare LLC)

重组人凝血因子Ⅷ（拜耳医药保健有限公司）

Report date: 2023/01/08 19:06:40

Base Information

Drug NameRecombinant human coagulation factor Ⅷ(Bayer HealthCare LLC Bayer HealthCare LLC)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionVon willebrand factor replacementsCoagulation factor X stimulants
TargetsCoagulation factor VIIICoagulation factor X
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesBayer Healthcare Pharmaceuticals LlcBayer Healthcare Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBayer Healthcare Pharmaceuticals LlcBayer Healthcare Company Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A